The Rogers Laboratory focuses on the development of novel radioactive probes for imaging and therapy. In particular, the laboratory uses radioactive metals that can be attached to proteins, peptides or small molecules. These metals can have physical properties that make them suitable for imaging (such as positron-emission tomography (PET)) or for therapy.  The delivery vehicles then bind to the specific target of interest in vivo.


The mission of the Rogers’ laboratory is to evaluate these radioactive probes both in vitro and in pre-clinical animal models such that they can be translated to the clinic to impact patient care.

Our laboratory is built on close collaboration between the Departments of Radiation Oncology, Radiology and Chemistry at Washington University.